Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3010% below fair value
$20.82+0.15 (+0.73%)
Close on Nov 13, 2026Market cap $23.91BP/E –Yield 2.31%
Viatris enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Viatris's enterprise value was $27.43B on Jan 31, 2025, against $31.30B a year earlier. Over the last 5 years it ranged from -$572.40M to $37.75B, with a median of $30.88B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2025 | Jan 31, 2025 | $27.43B | -4.9% |
| 2024 | Dec 31, 2024 | $28.84B | -4.4% |
| 2023 | Dec 29, 2023 | $30.16B | -6.8% |
| 2022 | Dec 30, 2022 | $32.35B | -10.5% |
| 2021 | Dec 31, 2021 | $36.14B | +232.4% |
| 2020 | Dec 31, 2020 | $10.87B | +8.8% |
| 2019 | Dec 31, 2019 | $9.99B | – |
See a number that looks wrong?